scientific program - World Allergy Organization

More documents

Recommendations

Info

MONDAY, 8 SEPTEMBER 36 MONDAY, 8 SEPTEMBER - continued Presenting authors indicated in bold. WAO Congress–XVIII ICACI Final Program Free Communication Session 15:45 - 17:15 FC3 -Asthma Therapy I Ballroom A, Vancouver Convention & Exhibition Centre CME Credit: 1.5 Co-Chair: Marek Kowalski, Poland Co-Chair: Juan Schuhl, Uruguay Abstract #O-3-1 Amelioration of asthma-like syndrome with a monoclonal antibody (mAb) specific for complement component C5 Peng T 1 , Hao L 2 , Sievers C 1 , Kristan J 1 , Wang Y 1 1 Alexion Pharmaceuticals Inc, Cheshire, CT, USA, 2 Yale University School of Medicine, New Haven, CT, USA Abstract #O-3-2 Anti-inflammatory effects of U0126, a MEK inhibitor, on a mouse model of asthma Duan W 1 1 National University of Singapore, Singapore, Singapore Abstract #O-17-5 Allergen avoidance and nasal topical corticosteroid in children with allergic rhinitis and mild asthma Reis AP 1 , Machado JAN 1 , Reis LL 1 1 Climed Clinics, Belo Horizonte, Minas Gerais, Brazil Abstract #O-3-4 Inpatient and emergency department visits among patients treated with fluticasone propionate and montelukast sodium Riedel AA 1 , Weiss KB 2 , Allen-Ramey FC 3 , Duong PT 3 , Markson LE 3 1 Ingenix, Inc., Economic and Outcomes Research Division, Eden Prairie, MN, USA, 2 Midwest Center for Health Services & Policy Research, Hines VA Hosp, Chicago, IL, USA, 3 Merck & Co., Inc., Outcomes Research & Management, West Point, PA, USA Abstract #O-3-5 Deposition of extrafine HFA-BDP inhaled via pMDI-spacer in asthmatic children Roller CM1 , Owen JL1 , Troedson RG2 , Le Souef PN1 , Devadason SG1 1University of Western Australia, Perth, Western Australia, Australia, 2Princess Margaret Hospital for Children, Perth, Western Australia, Australia Abstract #O-3-6 Effect of long-acting tulobuterol tape, a β-agonist transdermally absorbed, on airway hyperresponsiveness in pediatric patients with asthma Kurihara K 1 , Nishima S 2 , Baba M 3 1 Kanagawa Children’s Medical Center, Yokohama, Kanagawa, Japan, 2 National Minami-Fukuoka Hospital, Fukuoka, Fukuoka, Japan, 3 Doai Memorial Hospital, Tokyo, Tokyo, Japan SCIENTIFIC PROGRAM Free Communication Session 15:45 - 17:15 FC4 -Basic Mechanisms I Ballroom C, Vancouver Convention & Exhibition Centre CME Credit: 1.5 Co-Chair: Ken Ohta, Japan Co-Chair: Marc Rothenberg, United States Abstract #O-4-1 Regulation of interleukin-9 receptor expression by human neutrophils Takhar MK 1 , Soussi-Gounni A 1 1 Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada Abstract #O-4-2 Participation of Syk kinase in integrin signaling in airway epithelium Ulanova M 1 , Puttagunta L 1 , Schreiber AD 2 , Befus AD 1 1 University of Alberta, Edmonton, Canada, 2 University of Pennsylvania School of Medicine, Philadelphia, USA Abstract #O-4-3 Mechanisms of redirection of established allergen-specific Th2 biased responses in vivo: IFN-γ production and IL-12 responsiveness are critical Lewkowich IP 1 , HayGlass KT 1 1 Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada Abstract #O-4-4 Pollen associated lipid mediators (PALMs) inhibit dendritic cell IL-12 production resulting in a reduced capacity to initiate Th1 responses Jakob T 1 , Traidl-Hoffmann C 1 , Mariani V 1 , Hochrein H 2 , Ring J 3 , Behrendt H 1 1 ZAUM Center for Allergy and Environment TUM/GSF, Munich, Bavaria, Germany, 2 Institute of Medical Microbiology, Immunology and Hygiene, TUM, Munich, Germany, 3 Dept. of Dermatology and Allergy, Technische Universität, Munich, Germany Abstract #O-4-5 The ability of neonatal antigen presenting cells to undergo in-vitro maturation is associated with variations in allergen specific immune responses Upham JW 1 , Holt PG 1 , Thornton CA 2 , Prescott SL 3 1 Institute for Child Health Research, Perth, WA, Australia, 2 University of Southampton, Southampton, UK, 3 University of Western Australia, Perth, WA, Australia Abstract #O-4-6 FDC-SP is a novel chemoattractant for B cells activated by T-dependent signals Du Q 1 , Marshall AJ 1 1 University of Manitoba, Winnipeg, Manitoba, Canada
WAO Congress–XVIII ICACI Final Program MONDAY, 8 SEPTEMBER - continued SCIENTIFIC PROGRAM Free Communication Session 15:45 - 17:15 FC5 -Dermatitis Room 11, Vancouver Convention & Exhibition Centre CME Credit: 1.5 Chair: To be announced Abstract #O-5-1 Prevalence and associated factors of atopic eczema/dermatitis syndrome in rural and urban Ethiopia Flohr C 1 , Venn A 2 , Lewis SA 3 , Britton J 2 , Bekele Z 4 , Williams HC 1 , Parry E 5 , Yemaneberhan H 6 1 Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK, 2 Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK, 3 Division of Respiratory Medicine, University of Nottingham, Nottingham, UK, 4 Jimma Institute of Health Sciences, Jimma, Ethiopia, 5 Department Clin. Sci., London Sch. Hyg. & Trop. Med., London, UK, 6 University of Jimma, Jimma, Ethiopia Abstract #O-5-2 Prevalence of atopic dermatitis in early childhood in Japan: a nationwide survey Shimojo N 1 , Yamaguchi K 1 , Arima T 1 , Tomiita M 1 , Suzuki S 1 , Kohno Y 1 1 Department of Pediatrics, Graduate School of Medicine, Chiba Univ, Chiba, Japan Abstract #O-5-3 Efficacy of efomycine M in an animal model for contact dermatitis Zollner TM 1 , Schoen MP 2 , Podda M 3 , Asadullah K 1 , Boehncke WH 3 1 Research Business Area Dermatology, Schering AG, Berlin, Germany, 2 Dept. of Dermatology, Univ. of Magdeburg, Magdeburg, Germany, 3 Dept. of Dermatology, Univ. of Frankfurt, Frankfurt, Germany Abstract #O-5-4 Role of interleukin-18 in the development of dermatitis in atopic dermatitis-model mice NC/Nga Tanaka T 1 , Higa S 1 , Hirano T 1 , Kawase I 1 1 Department III Internal Medicine, Osaka University Medical School, Suita City, Osaka, Japan Abstract #O-5-5 Reduced cutaneous reactivity to vasoactive peptides in patients with atopic eczema Brockow K 1 , Reindel U 1 , Hermann K 2 , Huss-Marp J 2 , Abeck D 1 , Ring J 1 1 Dept. of Dermatology and Allergy Biederstein, TU Munich, Munich, Germany, 2 Division of Environmental Dermatology and Allergy GSF/ TUM, Munich, Germany Abstract #O-5-6 T cell reactions to paraphenylendiamine and its metabolites and different individual risk factors for sensitization Merk HF 1 , AlMasaoudi T 1 , Kawakubo Y 1 , Brams B 1 , Bloemeke B 1 1 Dept. of Dermatology & Allergy - RWTH Aachen, Aachen, Germany Presenting authors indicated in bold. Dinner Symposia 18:00 - 20:30 DS1 - Leukotriene Antagonists in the Treatment of Asthma and Allergic Rhinitis No fee. Dinner included. Meal and session limited to the first 300 delegates. Crystal Pavilion Ballroom, Pan Pacific Hotel Supported through an unrestricted educational grant from Ono Pharmaceutical Co. Ltd. CME Credit: 1.5 Chair: Terumasa Miyamoto, Japan Leukotriene Antagonists in the Management of Adult Asthma Paul O’Byrne, Canada Effect of Leukotriene Antagonists on Exercise Induced Asthma in Children Hiroyuki Mochizuki, Japan Clinical Consideration of Leukotriene Modifiers in the Treatment of Rhinitis Peter Creticos, United States DS2 - A Look to the Future: Advances in Inhaled Corticosteroid Therapy No fee. Dinner included. Meal and session limited to the first 300 delegates. Waterfront Ballroom, Fairmont Waterfront Hotel Supported through an unrestricted educational grant from Aventis Pharmaceuticals and ALTANA Pharma CME Credit: 1.5 Chair: Michael Kaliner, United States Asthma Epidemiology Gregory Diette, United States What is the Best Marker for Inhaled Corticosteroid Safety? Robert Dluhy, United States The “Ideal” Inhaled Corticosteroid Michael Kaliner, United States Downtown Vancouver 37 MONDAY, 8 SEPTEMBER
Page 1: FINAL PROGRAM World Allergy Organiz
Page 4 and 5: 2 WAO Congress-XVIII ICACI Final Pr
Page 6 and 7: 4 World Allergy Organization (WAO)-
Page 8 and 9: 6 WAO Congress-XVIII ICACI Final Pr
Page 10 and 11: 8 sneezing runny nose itchy nose it
Page 12 and 13: 10 PRECAUTIONS (continued) ADVERSE
Page 14 and 15: 12 WAO Congress-XVIII ICACI Final P
Page 23 and 24: WAO Congress-XVIII ICACI Final Prog
Page 25 and 26: Whistler alpine resort WAO Congress
Page 29 and 30: XXIII EAACI Congress 12-16 June 200
Page 31 and 32: 7:00 8:00 9:00 10:00 11:00 12:00 13
Page 37: WAO Congress-XVIII ICACI Final Prog
Page 49 and 50: WEDNESDAY WEDNESDAY SEPTEMBER SEPTE
Page 51 and 52: www.annualmeeting.aaaai.org Visit w
Page 59 and 60: Presenting authors indicated in bol
Page 61 and 62: FRIDAY, 12 SEPTEMBER WAO Congress-X
Page 63 and 64: Imagine research targeting IgE, a k
Page 89 and 90:
WAO Congress-XVIII ICACI Final Prog
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 98 and 99:
96 PLAN TO ATTEND! SOYEZ DES NÔTRE
Page 100 and 101:
98 Dolovich, Myrna Canada BR86 Dubo
Page 102 and 103:
100 Schnuch, Axel Germany BR88 Scho
Page 104 and 105:
102 201 ACII - Journal of the World
Page 106 and 107:
104 WAO Congress-XVIII ICACI Final
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
114 Crowne Plaza Hotel Georgia 801
Page 118 and 119:
Page 120 and 121:
118 (salmeterol xinafoate/fluticaso
Page 122 and 123:
COPD, the most commonly reported dr
Page 124 and 125:
Page 126 and 127:
124 Seaplane landing at sunset Gran
Page 128:
DS2 - Dinner Symposium Monday, 8 Se
show all

scientific program - World Allergy Organization

Create successful ePaper yourself

Delete template?

Save as template?